Phase I Study of Erlotinib Plus Radiation Therapy in Patients with Advanced Cutaneous Squamous Cell Carcinoma

PURPOSE: Recurrent or advanced stage cutaneous squamous cell carcinoma (cSCC) is difficult to treat and available therapies have a high failure rate. Anti-epidermal growth factor receptor therapy (EGFR) is associated with a facial rash that may potentiate radiation related cutaneous toxicities. The...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Heath, C. Hope, Deep, Nicholas L, Nabell, Lisle, Carroll, William R, Desmond, Renee, Clemons, Lisa, Spencer, Sharon, Magnuson, J. Scott, Rosenthal, Eben L
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607201/
https://ncbi.nlm.nih.gov/pubmed/23182701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2012.09.030
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky